<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36926608</PMID><DateRevised><Year>2023</Year><Month>03</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">1226-8453</ISSN><JournalIssue CitedMedium="Print"><Volume>47</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Journal of ginseng research</Title><ISOAbbreviation>J Ginseng Res</ISOAbbreviation></Journal><ArticleTitle>Antiviral Potential of the Genus <i>Panax</i>: An updated review on their effects and underlying mechanism of action.</ArticleTitle><Pagination><StartPage>183</StartPage><EndPage>192</EndPage><MedlinePgn>183-192</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jgr.2022.11.003</ELocationID><Abstract><AbstractText>Viral infections are known as one of the major factors causing death. Ginseng is a medicinal plant that demonstrated a wide range of antiviral potential, and saponins are the major bioactive ingredients in the genus <i>Panax</i> with vast therapeutic potential. Studies focusing on the antiviral activity of the genus <i>Panax</i> plant-derived agents (extracts and saponins) and their mechanisms were identified and summarized, including contributions mainly from January 2016 until January 2022. <i>P.&#xa0;ginseng</i>, <i>P.&#xa0;notoginseng</i>, and <i>P.&#xa0;quinquefolius</i> were included in the review as valuable medicinal herbs against infections with 14 types of viruses. Reports from 9 extracts and 12 bioactive saponins were included, with 6 types of protopanaxadiol (PPD) ginsenosides and 6 types of protopanaxatriol (PPT) ginsenosides. The mechanisms mainly involved the inhibition of viral attachment and replication, the modulation of immune response by regulating signaling pathways, including the Janus kinase (JAK)/signal transducer and activator of transcription (STAT) pathway, cystathionine &#x3b3;-lyase (CSE)/hydrogen sulfide (H<sub>2</sub>S) pathway, phosphoinositide-dependent kinase-1 (PDK1)/ protein kinase B (Akt) signaling pathway, c-Jun N-terminal kinase (JNK)/activator protein-1 (AP-1) pathway, and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-&#x3ba;B) pathway. This review includes detailed information about the mentioned antiviral effects of the genus <i>Panax</i> extracts and saponins <i>in&#xa0;vitro</i> and <i>in&#xa0;vivo</i>, and in human clinical trials, which provides a scientific basis for ginseng as an adjunctive therapeutic drug or nutraceutical.</AbstractText><CopyrightInformation>&#xa9; 2022 The Korean Society of Ginseng. Publishing services by Elsevier B.V.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yibo</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Engineering Research Center of Shanghai Colleges for TCM New Drug Discovery, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhong</LastName><ForeName>Xuanlei</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Engineering Research Center of Shanghai Colleges for TCM New Drug Discovery, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xi</LastName><ForeName>Zhichao</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Engineering Research Center of Shanghai Colleges for TCM New Drug Discovery, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Engineering Research Center of Shanghai Colleges for TCM New Drug Discovery, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Hongxi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>Korea (South)</Country><MedlineTA>J Ginseng Res</MedlineTA><NlmUniqueID>100890690</NlmUniqueID><ISSNLinking>1226-8453</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ARI, acute respiratory illness</Keyword><Keyword MajorTopicYN="N">BG, black ginseng</Keyword><Keyword MajorTopicYN="N">BVDV, bovine viral diarrhea virus</Keyword><Keyword MajorTopicYN="N">CHB, chronic hepatitis B</Keyword><Keyword MajorTopicYN="N">CSFV, classical swine fever virus</Keyword><Keyword MajorTopicYN="N">CVBs, group B coxsackieviruses</Keyword><Keyword MajorTopicYN="N">DAA, direct-acting antiviral therapies</Keyword><Keyword MajorTopicYN="N">EBV, the Epstein-Barr virus</Keyword><Keyword MajorTopicYN="N">EV, enterovirus</Keyword><Keyword MajorTopicYN="N">EV71, human enterovirus 71</Keyword><Keyword MajorTopicYN="N">GCRV, grass carp reovirus</Keyword><Keyword MajorTopicYN="N">GSLS, Ginseng stem-leaf saponins</Keyword><Keyword MajorTopicYN="N">HAART, highly active antiretroviral drug therapy</Keyword><Keyword MajorTopicYN="N">HBV, hepatitis B virus</Keyword><Keyword MajorTopicYN="N">HCV, Hepatitis C virus</Keyword><Keyword MajorTopicYN="N">HIV-1, human immunodeficiency virus type 1</Keyword><Keyword MajorTopicYN="N">HP, highly pathogenic</Keyword><Keyword MajorTopicYN="N">HSV, herpes simplex virus</Keyword><Keyword MajorTopicYN="N">HVJ, hemagglutinating virus of Japan</Keyword><Keyword MajorTopicYN="N">IFN-1, type-I interferon</Keyword><Keyword MajorTopicYN="N">JAK, janus kinase</Keyword><Keyword MajorTopicYN="N">JNK, c-Jun N-terminal kinase</Keyword><Keyword MajorTopicYN="N">KRG, Korean Red Ginseng</Keyword><Keyword MajorTopicYN="N">KSHV, Kaposi's sarcoma-associated herpesvirus</Keyword><Keyword MajorTopicYN="N">MHV-68, murine gammaherpesvirus 68</Keyword><Keyword MajorTopicYN="N">NDV, Newcastle disease virus</Keyword><Keyword MajorTopicYN="N">NK, natural killer</Keyword><Keyword MajorTopicYN="N">PNAB, PEGylated nanoparticle albumin-bound</Keyword><Keyword MajorTopicYN="N">PNR, P.&#xa0;notoginseng root water extract</Keyword><Keyword MajorTopicYN="N">PPD, protopanaxadiol</Keyword><Keyword MajorTopicYN="N">PPT, protopanaxatriol</Keyword><Keyword MajorTopicYN="N">PRRSV, porcine reproductive and respiratory syndrome virus</Keyword><Keyword MajorTopicYN="N">Panax ginseng</Keyword><Keyword MajorTopicYN="N">RSV, respiratory syncytial virus</Keyword><Keyword MajorTopicYN="N">RV, rotavirus</Keyword><Keyword MajorTopicYN="N">STAT, signal transducer and activator of transcription</Keyword><Keyword MajorTopicYN="N">antiviral activity</Keyword><Keyword MajorTopicYN="N">ginseng</Keyword><Keyword MajorTopicYN="N">ginsenosides</Keyword><Keyword MajorTopicYN="N">mechanism of action</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>10</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>17</Day><Hour>2</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>18</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>11</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36926608</ArticleId><ArticleId IdType="pmc">PMC10014226</ArticleId><ArticleId IdType="doi">10.1016/j.jgr.2022.11.003</ArticleId><ArticleId IdType="pii">S1226-8453(22)00151-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Pecora F., Persico F., Argentiero A., Neglia C., Esposito S. The role of micronutrients in support of the immune response against viral infections. Nutrients. 2020;12(10)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7589163</ArticleId><ArticleId IdType="pubmed">33092041</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang C., Lu L.F., Li Z.C., Zhou X.Y., Zhou Y., Chen D.D., Li S., Zhang Y.A. Grass carp reovirus VP56 represses interferon production by degrading phosphorylated IRF7. Fish Shellfish Immunol. 2020;99:99&#x2013;106.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7111710</ArticleId><ArticleId IdType="pubmed">32032764</ArticleId></ArticleIdList></Reference><Reference><Citation>Lundstrom K. Self-amplifying RNA viruses as RNA vaccines. Int J Mol Sci. 2020;21(14)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7404065</ArticleId><ArticleId IdType="pubmed">32698494</ArticleId></ArticleIdList></Reference><Reference><Citation>Lampejo T. Influenza and antiviral resistance: an overview. Eur J Clin Microbiol Infect Dis. 2020;39(7):1201&#x2013;1208.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7223162</ArticleId><ArticleId IdType="pubmed">32056049</ArticleId></ArticleIdList></Reference><Reference><Citation>Park S.E., Na C.S., Yoo S.A., Seo S.H., Son H.S. Biotransformation of major ginsenosides in ginsenoside model culture by lactic acid bacteria. J&#xa0;Ginseng Res. 2017;41(1):36&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5223066</ArticleId><ArticleId IdType="pubmed">28123320</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohanan P., Subramaniyam S., Mathiyalagan R., Yang D.C. Molecular signaling of ginsenosides Rb1, Rg1, and Rg3 and their mode of actions. J&#xa0;Ginseng Res. 2018;42(2):123&#x2013;132.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5926405</ArticleId><ArticleId IdType="pubmed">29719458</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai L., Gao J., Wei F., Zhao J., Wang D., Wei J. Therapeutic potential of ginsenosides as an adjuvant treatment for diabetes. Front Pharmacol. 2018;9:423.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5938666</ArticleId><ArticleId IdType="pubmed">29765322</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu H., Lu X., Hu Y., Fan X. Chemical constituents of Panax ginseng and Panax notoginseng explain why they differ in therapeutic efficacy. Pharmacol Res. 2020;161</Citation><ArticleIdList><ArticleId IdType="pubmed">33127555</ArticleId></ArticleIdList></Reference><Reference><Citation>Szczuka D., Nowak A., Zaklos-Szyda M., Kochan E., Szymanska G., Motyl I., Blasiak J. American ginseng (Panax quinquefolium L.) as a source of bioactive phytochemicals with pro-health properties. Nutrients. 2019;11(5)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6567205</ArticleId><ArticleId IdType="pubmed">31075951</ArticleId></ArticleIdList></Reference><Reference><Citation>Piao X.M., Huo Y., Kang J.P., Mathiyalagan R., Zhang H., Yang D.U., Kim M., Yang D.C., Kang S.C., Wang Y.P. Diversity of ginsenoside profiles produced by various processing technologies. Molecules. 2020;25(19)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7582514</ArticleId><ArticleId IdType="pubmed">32987784</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen N.H., Nguyen C.T. Pharmacological effects of ginseng on infectious diseases. Inflammopharmacology. 2019;27(5):871&#x2013;883.</Citation><ArticleIdList><ArticleId IdType="pubmed">31407196</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang T., Zhong S., Hou L., Wang Y., Xing X., Guan T., Zhang J., Li T. Computational and experimental characterization of estrogenic activities of 20(S, R)-protopanaxadiol and 20(S, R)-protopanaxatriol. J&#xa0;Ginseng Res. 2020;44(5):690&#x2013;696.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7471209</ArticleId><ArticleId IdType="pubmed">32913398</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin B.K., Kwon S.W., Park J.H. Chemical diversity of ginseng saponins from Panax ginseng. J&#xa0;Ginseng Res. 2015;39(4):287&#x2013;298.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4593792</ArticleId><ArticleId IdType="pubmed">26869820</ArticleId></ArticleIdList></Reference><Reference><Citation>Wensvoort G., Terpstra C., Pol J.M., ter Laak E.A., Bloemraad M., de Kluyver E.P., Kragten C., van Buiten L., den Besten A., Wagenaar F., et al. Mystery swine disease in The Netherlands: the isolation of Lelystad virus. Vet Q. 1991;13(3):121&#x2013;130.</Citation><ArticleIdList><ArticleId IdType="pubmed">1835211</ArticleId></ArticleIdList></Reference><Reference><Citation>Du T., Nan Y., Xiao S., Zhao Q., Zhou E.M. Antiviral strategies against PRRSV infection. Trends Microbiol. 2017;25(12):968&#x2013;979.</Citation><ArticleIdList><ArticleId IdType="pubmed">28652073</ArticleId></ArticleIdList></Reference><Reference><Citation>Kappes M.A., Faaberg K.S. PRRSV structure, replication and recombination: origin of phenotype and genotype diversity. Virology. 2015;479&#x2013;480:475&#x2013;486.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7111637</ArticleId><ArticleId IdType="pubmed">25759097</ArticleId></ArticleIdList></Reference><Reference><Citation>Lunney J.K., Fang Y., Ladinig A., Chen N., Li Y., Rowland B., Renukaradhya G.J. Porcine reproductive and respiratory syndrome virus (PRRSV): pathogenesis and interaction with the immune system. Annu Rev Anim Biosci. 2016;4:129&#x2013;154.</Citation><ArticleIdList><ArticleId IdType="pubmed">26646630</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Z.Q., Yi H.Y., Ma J., Wei Y.F., Cai M.K., Li Q., Qin C.X., Chen Y.J., Han X.L., Zhong R.T., et al. Ginsenoside Rg1 suppresses type 2 PRRSV infection via NF-kappaB signaling pathway in&#xa0;vitro, and provides partial protection against HP-PRRSV in piglet. Viruses. 2019;11(11)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6893584</ArticleId><ArticleId IdType="pubmed">31717616</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Y., Zhang B., Wang W., Zhou J., Li B., He K. Therapeutic effects of saponin components on porcine reproductive and respiratory syndrome virus-infected piglets. J&#xa0;Anim Physiol Anim Nutr (Berl). 2020;104(2):637&#x2013;644.</Citation><ArticleIdList><ArticleId IdType="pubmed">31898833</ArticleId></ArticleIdList></Reference><Reference><Citation>Webster R.G., Bean W.J., Gorman O.T., Chambers T.M., Kawaoka Y. Evolution and ecology of influenza A viruses. Microbiol Rev. 1992;56(1):152&#x2013;179.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC372859</ArticleId><ArticleId IdType="pubmed">1579108</ArticleId></ArticleIdList></Reference><Reference><Citation>Takashita E., Ichikawa M., Morita H., Ogawa R., Fujisaki S., Shirakura M., Miura H., Nakamura K., Kishida N., Kuwahara T., et al. Human-to-Human transmission of influenza A(H3N2) virus with reduced susceptibility to baloxavir, Japan, february 2019. Emerg Infect Dis. 2019;25(11):2108&#x2013;2111.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6810216</ArticleId><ArticleId IdType="pubmed">31436527</ArticleId></ArticleIdList></Reference><Reference><Citation>Joseph U., Su Y.C., Vijaykrishna D., Smith G.J. The ecology and adaptive evolution of influenza A interspecies transmission. Influenza Other Respir Viruses. 2017;11(1):74&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5155642</ArticleId><ArticleId IdType="pubmed">27426214</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong W., Farooqui A., Leon A.J., Kelvin D.J. Inhibition of influenza A virus infection by ginsenosides. PLoS One. 2017;12(2)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5302443</ArticleId><ArticleId IdType="pubmed">28187149</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi J.G., Jin Y.H., Lee H., Oh T.W., Yim N.H., Cho W.K., Ma J.Y. Protective effect of Panax notoginseng root water extract against influenza A virus infection by enhancing antiviral interferon-mediated immune responses and natural killer cell activity. Front Immunol. 2017;8:1542.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5693858</ArticleId><ArticleId IdType="pubmed">29181006</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwon E.B., Oh Y.C., Hwang Y.H., Li W., Park S.M., Kong R., Kim Y.S., Choi J.G. A&#xa0;herbal mixture formula of OCD20015-V009 prophylactic administration to enhance interferon-mediated antiviral activity against influenza A virus. Front Pharmacol. 2021;12</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8651992</ArticleId><ArticleId IdType="pubmed">34899320</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Jung Y.J., Kim K.H., Kwon Y., Kim Y.J., Zhang Z., Kang H.S., Wang B.Z., Quan F.S., Kang S.M. Antiviral activity of fermented ginseng extracts against a broad range of influenza viruses. Viruses. 2018;10(9)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6164659</ArticleId><ArticleId IdType="pubmed">30200514</ArticleId></ArticleIdList></Reference><Reference><Citation>Park E.H., Yum J., Ku K.B., Kim H.M., Kang Y.M., Kim J.C., Kim J.A., Kang Y.K., Seo S.H. Red Ginseng-containing diet helps to protect mice and ferrets from the lethal infection by highly pathogenic H5N1 influenza virus. J&#xa0;Ginseng Res. 2014;38(1):40&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3915332</ArticleId><ArticleId IdType="pubmed">24558309</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim E.H., Kim S.W., Park S.J., Kim S., Yu K.M., Kim S.G., Lee S.H., Seo Y.K., Cho N.H., Kang K., et al. Greater efficacy of black ginseng (cj EnerG) over red ginseng against lethal influenza A virus infection. Nutrients. 2019;11(8)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6723933</ArticleId><ArticleId IdType="pubmed">31412594</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H., Jang M., Kim Y., Choi J., Jeon J., Kim J., Hwang Y.I., Kang J.S., Lee W.J. Red ginseng and vitamin C increase immune cell activity and decrease lung inflammation induced by influenza A virus/H1N1 infection. J&#xa0;Pharm Pharmacol. 2016;68(3):406&#x2013;420.</Citation><ArticleIdList><ArticleId IdType="pubmed">26898166</ArticleId></ArticleIdList></Reference><Reference><Citation>Sreekanth T.V.M., Nagajyothi P.C., Muthuraman P., Enkhtaivan G., Vattikuti S.V.P., Tettey C.O., Kim D.H., Shim J., Yoo K. Ultra-sonication-assisted silver nanoparticles using Panax ginseng root extract and their anti-cancer and antiviral activities. J&#xa0;Photochem Photobiol B. 2018;188:6&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pubmed">30176393</ArticleId></ArticleIdList></Reference><Reference><Citation>McElhaney J.E., Gravenstein S., Cole S.K., Davidson E., O'Neill D., Petitjean S., Rumble B., Shan J.J. A&#xa0;placebo-controlled trial of a proprietary extract of North American ginseng (CVT-E002) to prevent acute respiratory illness in institutionalized older adults. J&#xa0;Am Geriatr Soc. 2004;52(1):13&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pubmed">14687309</ArticleId></ArticleIdList></Reference><Reference><Citation>Sung H., Jung Y.S., Kang M.W., Bae I.G., Chang H.H., Woo J.H., Cho Y.K. High frequency of drug resistance mutations in human immunodeficiency virus type 1-infected Korean patients treated with HAART. AIDS Res Hum Retroviruses. 2007;23(10):1223&#x2013;1229.</Citation><ArticleIdList><ArticleId IdType="pubmed">17961108</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu D.Y., Wu H.Y., Yarla N.S., Xu B., Ding J., Lu T.R. HAART in HIV/AIDS treatments: future trends. Infect Disord Drug Targets. 2018;18(1):15&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">28474549</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho Y.K., Kim J.E. Effect of Korean Red Ginseng intake on the survival duration of human immunodeficiency virus type 1 patients. J&#xa0;Ginseng Res. 2017;41(2):222&#x2013;226.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5386125</ArticleId><ArticleId IdType="pubmed">28413328</ArticleId></ArticleIdList></Reference><Reference><Citation>Sung H., Kang S.M., Lee M.S., Kim T.G., Cho Y.K. Korean red ginseng slows depletion of CD4 T cells in human immunodeficiency virus type 1-infected patients. Clin Diagn Lab Immunol. 2005;12(4):497&#x2013;501.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1074393</ArticleId><ArticleId IdType="pubmed">15817756</ArticleId></ArticleIdList></Reference><Reference><Citation>Sung H., Jung Y.S., Cho Y.K. Beneficial effects of a combination of Korean red ginseng and highly active antiretroviral therapy in human immunodeficiency virus type 1-infected patients. Clin Vaccine Immunol. 2009;16(8):1127&#x2013;1131.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2725544</ArticleId><ArticleId IdType="pubmed">19535541</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho Y.K., Kim J.E. The frequency of defective genes in vif and vpr genes in 20 hemophiliacs is associated with Korean Red Ginseng and highly active antiretroviral therapy: the impact of lethal mutations in vif and vpr genes on HIV-1 evolution. J&#xa0;Ginseng Res. 2021;45(1):149&#x2013;155.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7790868</ArticleId><ArticleId IdType="pubmed">33437166</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho Y.K., Kim J.E., Woo J.H. Korean Red Ginseng increases defective pol gene in peripheral blood mononuclear cells of HIV-1-infected patients; inhibition of its detection during ginseng-based combination therapy. J&#xa0;Ginseng Res. 2019;43(4):684&#x2013;691.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6823744</ArticleId><ArticleId IdType="pubmed">31695572</ArticleId></ArticleIdList></Reference><Reference><Citation>Baggen J., Thibaut H.J., Strating J., van Kuppeveld F.J.M. The life cycle of non-polio enteroviruses and how to target it. Nat Rev Microbiol. 2018;16(6):368&#x2013;381.</Citation><ArticleIdList><ArticleId IdType="pubmed">29626210</ArticleId></ArticleIdList></Reference><Reference><Citation>Khanna M., Gautam A., Rajput R., Sharma L. Natural products as a paradigm for the treatment of coxsackievirus - induced myocarditis. Curr Top Med Chem. 2020;20(8):607&#x2013;616.</Citation><ArticleIdList><ArticleId IdType="pubmed">31995007</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan L., Zhang Y., Lu J., Geng Z., Jia L., Rong X., Wang Z., Zhao Q., Wu R., Chu M., et al. Panax notoginseng saponins ameliorates coxsackievirus B3-induced myocarditis by activating the cystathionine-gamma-lyase/hydrogen sulfide pathway. J&#xa0;Cardiovasc Transl Res. 2015;8(9):536&#x2013;544.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4674358</ArticleId><ArticleId IdType="pubmed">26525047</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X., Wang Y., Ren Z., Qian C., Li Y., Wang Q., Zhang Y., Zheng L., Jiang J., Yang C., et al. Protective effects of 20(s)-protopanaxtriol on viral myocarditis infected by coxsackievirus B3. Pathobiology. 2012;79(6):285&#x2013;289.</Citation><ArticleIdList><ArticleId IdType="pubmed">22688124</ArticleId></ArticleIdList></Reference><Reference><Citation>Ventarola D., Bordone L., Silverberg N. Update on hand-foot-and-mouth disease. Clin Dermatol. 2015;33(3):340&#x2013;346.</Citation><ArticleIdList><ArticleId IdType="pubmed">25889136</ArticleId></ArticleIdList></Reference><Reference><Citation>You L., Chen J., Liu W., Xiang Q., Luo Z., Wang W., Xu W., Wu K., Zhang Q., Liu Y., et al. Enterovirus 71 induces neural cell apoptosis and autophagy through promoting ACOX1 downregulation and ROS generation. Virulence. 2020;11(1):537&#x2013;553.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7250321</ArticleId><ArticleId IdType="pubmed">32434419</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang N., Gao H., He L., Liu Y., Fan H., Xu Q., Yang S. Ginsenoside Rb1 is an immune-stimulatory agent with antiviral activity against enterovirus 71. J&#xa0;Ethnopharmacol. 2021;266</Citation><ArticleIdList><ArticleId IdType="pubmed">32980486</ArticleId></ArticleIdList></Reference><Reference><Citation>Song J.H., Choi H.J., Song H.H., Hong E.H., Lee B.R., Oh S.R., Choi K., Yeo S.G., Lee Y.P., Cho S., et al. Antiviral activity of ginsenosides against coxsackievirus B3, enterovirus 71, and human rhinovirus 3. J&#xa0;Ginseng Res. 2014;38(3):173&#x2013;179.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4213867</ArticleId><ArticleId IdType="pubmed">25378991</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergroth E., Aakula M., Elenius V., Remes S., Piippo-Savolainen E., Korppi M., Piedra P.A., Bochkov Y.A., Gern J.E., Camargo C.A., Jr., et al. Rhinovirus type in severe bronchiolitis and the development of asthma. J&#xa0;Allergy Clin Immunol Pract. 2020;8(2):588&#x2013;595 e4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7012669</ArticleId><ArticleId IdType="pubmed">31520837</ArticleId></ArticleIdList></Reference><Reference><Citation>Makris S., Johnston S. Recent advances in understanding rhinovirus immunity. F1000Res. 2018;7</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6173106</ArticleId><ArticleId IdType="pubmed">30345002</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukushima A., Yoo Y.C., Yoshimatsu K., Matsuzawa K., Tamura M., Tono-oka S., Taniguchi K., Urasawa S., Arikawa J., Azuma I. Effect of MDP-Lys(L18) as a mucosal immunoadjuvant on protection of mucosal infections by Sendai virus and rotavirus. Vaccine. 1996;14(6):485&#x2013;491.</Citation><ArticleIdList><ArticleId IdType="pubmed">8782344</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoo Y.C., Lee J., Park S.R., Nam K.Y., Cho Y.H., Choi J.E. Protective effect of ginsenoside-Rb2 from Korean red ginseng on the lethal infection of haemagglutinating virus of Japan in mice. J&#xa0;Ginseng Res. 2013;37(1):80&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3659615</ArticleId><ArticleId IdType="pubmed">23717160</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadiq A., Bostan N., Yinda K.C., Naseem S., Sattar S. Rotavirus: genetics, pathogenesis and vaccine advances. Rev Med Virol. 2018;28(6)</Citation><ArticleIdList><ArticleId IdType="pubmed">30156344</ArticleId></ArticleIdList></Reference><Reference><Citation>Mortality G.B.D. Causes of Death C. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388:1459&#x2013;1544. 10053.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5388903</ArticleId><ArticleId IdType="pubmed">27733281</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang H., Oh K.H., Kim H.J., Cho Y.H., Yoo Y.C. Ginsenoside-Rb2 and 20(S)-Ginsenoside-Rg3 from Korean red ginseng prevent rotavirus infection in newborn mice. J&#xa0;Microbiol Biotechnol. 2018;28(3):391&#x2013;396.</Citation><ArticleIdList><ArticleId IdType="pubmed">29316736</ArticleId></ArticleIdList></Reference><Reference><Citation>Connolly S.A., Jardetzky T.S., Longnecker R. The structural basis of herpesvirus entry. Nat Rev Microbiol. 2021;19(2):110&#x2013;121.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8579738</ArticleId><ArticleId IdType="pubmed">33087881</ArticleId></ArticleIdList></Reference><Reference><Citation>Dadwal S.S. Herpes virus infections other than cytomegalovirus in the recipients of hematopoietic stem cell transplantation. Infect Dis Clin North Am. 2019;33(2):467&#x2013;484.</Citation><ArticleIdList><ArticleId IdType="pubmed">31005137</ArticleId></ArticleIdList></Reference><Reference><Citation>Simas J.P., Efstathiou S. Murine gammaherpesvirus 68: a model for the study of gammaherpesvirus pathogenesis. Trends Microbiol. 1998;6(7):276&#x2013;282.</Citation><ArticleIdList><ArticleId IdType="pubmed">9717216</ArticleId></ArticleIdList></Reference><Reference><Citation>Aligo J., Walker M., Bugelski P., Weinstock D. Is murine gammaherpesvirus-68 (MHV-68) a suitable immunotoxicological model for examining immunomodulatory drug-associated viral recrudescence? J&#xa0;Immunotoxicol. 2015;12(1):1&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">24512328</ArticleId></ArticleIdList></Reference><Reference><Citation>Manners O., Murphy J.C., Coleman A., Hughes D.J., Whitehouse A. Contribution of the KSHV and EBV lytic cycles to tumourigenesis. Curr Opin Virol. 2018;32:60&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6259586</ArticleId><ArticleId IdType="pubmed">30268927</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang S., Im K., Kim G., Min H. Antiviral activity of 20(R)-ginsenoside Rh2 against murine gammaherpesvirus. J&#xa0;Ginseng Res. 2017;41(4):496&#x2013;502.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5628367</ArticleId><ArticleId IdType="pubmed">29021696</ArticleId></ArticleIdList></Reference><Reference><Citation>Wright S., Altman E. Inhibition of herpes simplex viruses, types 1 and 2, by ginsenoside 20(S)-Rg3. J&#xa0;Microbiol Biotechnol. 2020;30(1):101&#x2013;108.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9728284</ArticleId><ArticleId IdType="pubmed">31693840</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang S., Song M.J., Min H. Antiviral activity of ginsenoside Rg3 isomers against gammaherpesvirus through inhibition of p38- and JNK-associated pathways. Journal of Functional Foods. 2018;40:219&#x2013;228.</Citation></Reference><Reference><Citation>Petti S., Lodi G. The controversial natural history of oral herpes simplex virus type 1 infection. Oral Dis. 2019;25(8):1850&#x2013;1865.</Citation><ArticleIdList><ArticleId IdType="pubmed">31733122</ArticleId></ArticleIdList></Reference><Reference><Citation>Schiffer J.T., Gottlieb S.L. Biologic interactions between HSV-2 and HIV-1 and possible implications for HSV vaccine development. Vaccine. 2019;37(50):7363&#x2013;7371.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5867191</ArticleId><ArticleId IdType="pubmed">28958807</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu X., Zhang Y., Li Q. Characteristics of herpes simplex virus infection and pathogenesis suggest a strategy for vaccine development. Rev Med Virol. 2019;29(4)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6771534</ArticleId><ArticleId IdType="pubmed">31197909</ArticleId></ArticleIdList></Reference><Reference><Citation>Daikoku T., Tannai H., Honda M., Onoe T., Matsuo K., Onoye Y., Nishizawa M., Kawana T., Okuda T., Hasegawa T., et al. Subclinical generation of acyclovir-resistant herpes simplex virus with mutation of homopolymeric guanosine strings during acyclovir therapy. J&#xa0;Dermatol Sci. 2016;82(3):160&#x2013;165.</Citation><ArticleIdList><ArticleId IdType="pubmed">26917345</ArticleId></ArticleIdList></Reference><Reference><Citation>Anton-Vazquez V., Mehra V., Mbisa J.L., Bradshaw D., Basu T.N., Daly M.L., Mufti G.J., Pagliuca A., Potter V., Zuckerman M. Challenges of aciclovir-resistant HSV infection in allogeneic bone marrow transplant recipients. J&#xa0;Clin Virol. 2020;128</Citation><ArticleIdList><ArticleId IdType="pubmed">32417677</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho A., Roh Y.S., Uyangaa E., Park S., Kim J.W., Lim K.H., Kwon J., Eo S.K., Lim C.W., Kim B. Protective effects of red ginseng extract against vaginal herpes simplex virus infection. J&#xa0;Ginseng Res. 2013;37(2):210&#x2013;218.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3659631</ArticleId><ArticleId IdType="pubmed">23717174</ArticleId></ArticleIdList></Reference><Reference><Citation>Heim K., Neumann-Haefelin C., Thimme R., Hofmann M. Heterogeneity of HBV-specific CD8(+) T-cell failure: implications for immunotherapy. Front Immunol. 2019;10:2240.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6763562</ArticleId><ArticleId IdType="pubmed">31620140</ArticleId></ArticleIdList></Reference><Reference><Citation>Gane E.J. Future anti-HBV strategies. Liver Int. 2017;37(Suppl 1):40&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pubmed">28052637</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi S.H., Yang K.J., Lee D.S. Effects of complementary combination therapy of Korean red ginseng and antiviral agents in chronic hepatitis B. J&#xa0;Altern Complement Med. 2016;22(12):964&#x2013;969.</Citation><ArticleIdList><ArticleId IdType="pubmed">27603149</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang L.J., Choi Y.J., Lee S.G. Stimulation of TRAF6/TAK1 degradation and inhibition of JNK/AP-1 signalling by ginsenoside Rg3 attenuates hepatitis B virus replication. Int J Biochem Cell Biol. 2013;45(11):2612&#x2013;2621.</Citation><ArticleIdList><ArticleId IdType="pubmed">24004833</ArticleId></ArticleIdList></Reference><Reference><Citation>Westerhoff M., Ahn J. Chronic hepatitis C and direct acting antivirals. Surg Pathol Clin. 2018;11(2):287&#x2013;296.</Citation><ArticleIdList><ArticleId IdType="pubmed">29751875</ArticleId></ArticleIdList></Reference><Reference><Citation>Baumert T.F., Berg T., Lim J.K., Nelson D.R. Status of direct-acting antiviral therapy for hepatitis C virus infection and remaining challenges. Gastroenterology. 2019;156(2):431&#x2013;445.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6446912</ArticleId><ArticleId IdType="pubmed">30342035</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S.J., Syed G.H., Khan M., Chiu W.W., Sohail M.A., Gish R.G., Siddiqui A. Hepatitis C virus triggers mitochondrial fission and attenuates apoptosis to promote viral persistence. Proc Natl Acad Sci U S A. 2014;111(17):6413&#x2013;6418.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4035934</ArticleId><ArticleId IdType="pubmed">24733894</ArticleId></ArticleIdList></Reference><Reference><Citation>Jassey A., Liu C.H., Changou C.A., Richardson C.D., Hsu H.Y., Lin L.T. Hepatitis C virus non-structural protein 5A (NS5A) disrupts mitochondrial dynamics and induces mitophagy. Cells. 2019;8(4)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6523690</ArticleId><ArticleId IdType="pubmed">30934919</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S.J., Jang J.Y., Kim E.J., Cho E.K., Ahn D.G., Kim C., Park H.S., Jeong S.W., Lee S.H., Kim S.G., et al. Ginsenoside Rg3 restores hepatitis C virus-induced aberrant mitochondrial dynamics and inhibits virus propagation. Hepatology. 2017;66(3):758&#x2013;771.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5755973</ArticleId><ArticleId IdType="pubmed">28329914</ArticleId></ArticleIdList></Reference><Reference><Citation>Reshi L., Wu J.L., Wang H.V., Hong J.R. Aquatic viruses induce host cell death pathways and its application. Virus Res. 2016;211:133&#x2013;144.</Citation><ArticleIdList><ArticleId IdType="pubmed">26494167</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai J., Zhang L., Zhang P., Shu H., Mao A., Li Y. Ginsenoside Rg3 inhibits grass carp reovirus replication in grass carp ovarian epithelial cells. Microb Pathog. 2020;144</Citation><ArticleIdList><ArticleId IdType="pubmed">32224212</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox R.M., Plemper R.K. Structure and organization of paramyxovirus particles. Curr Opin Virol. 2017;24:105&#x2013;114.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5529233</ArticleId><ArticleId IdType="pubmed">28601688</ArticleId></ArticleIdList></Reference><Reference><Citation>Gowthaman V., Singh S.D., Dhama K., Desingu P.A., Kumar A., Malik Y.S., Munir M. Isolation and characterization of genotype XIII Newcastle disease virus from Emu in India. Virusdisease. 2016;27(3):315&#x2013;318.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5394700</ArticleId><ArticleId IdType="pubmed">28466046</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma X., Bi S., Wang Y., Chi X., Hu S. Combined adjuvant effect of ginseng stem-leaf saponins and selenium on immune responses to a live bivalent vaccine of Newcastle disease virus and infectious bronchitis virus in chickens. Poult Sci. 2019;98(9):3548&#x2013;3556.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7107245</ArticleId><ArticleId IdType="pubmed">31220864</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhai L., Li Y., Wang W., Wang Y., Hu S. Effect of oral administration of ginseng stem-and-leaf saponins (GSLS) on the immune responses to Newcastle disease vaccine in chickens. Vaccine. 2011;29(31):5007&#x2013;5014.</Citation><ArticleIdList><ArticleId IdType="pubmed">21569814</ArticleId></ArticleIdList></Reference><Reference><Citation>Blome S., Staubach C., Henke J., Carlson J., Beer M. Classical swine fever-an updated review. Viruses. 2017;9(4)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5408692</ArticleId><ArticleId IdType="pubmed">28430168</ArticleId></ArticleIdList></Reference><Reference><Citation>Chernick A., Ambagala A., Orsel K., Wasmuth J.D., van Marle G., van der Meer F. Bovine viral diarrhea virus genomic variation within persistently infected cattle. Infect Genet Evol. 2018;58:218&#x2013;223.</Citation><ArticleIdList><ArticleId IdType="pubmed">29306002</ArticleId></ArticleIdList></Reference><Reference><Citation>Pecora A., Perez Aguirreburualde M.S., Ridpath J.F., Dus Santos M.J. Molecular characterization of pestiviruses in fetal bovine sera originating from Argentina: evidence of circulation of HoBi-like viruses. Front Vet Sci. 2019;6:359.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6805694</ArticleId><ArticleId IdType="pubmed">31681812</ArticleId></ArticleIdList></Reference><Reference><Citation>Tong W., Zheng H., Li G.X., Gao F., Shan T.L., Zhou Y.J., Yu H., Jiang Y.F., Yu L.X., Li L.W., et al. Recombinant pseudorabies virus expressing E2 of classical swine fever virus (CSFV) protects against both virulent pseudorabies virus and CSFV. Antiviral Res. 2020;173</Citation><ArticleIdList><ArticleId IdType="pubmed">31751590</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan B., Giangaspero M., Sun N., Jin Y., Liu K., Wang Q., Cheng S., Wang Y., Zhang S. Antiviral effect of ginsenoside Rb2 and Rb3 against bovine viral diarrhea virus and classical swine fever virus in&#xa0;vitro. Front Vet Sci. 2021;8</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8692705</ArticleId><ArticleId IdType="pubmed">34957281</ArticleId></ArticleIdList></Reference><Reference><Citation>Nam H.H., Ison M.G. Respiratory syncytial virus infection in adults. BMJ. 2019;366:l5021.</Citation><ArticleIdList><ArticleId IdType="pubmed">31506273</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi T., McAllister D.A., O'Brien K.L., Simoes E.A.F., Madhi S.A., Gessner B.D., Polack F.P., Balsells E., Acacio S., Aguayo C., et al. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study. Lancet. 2017;390:946&#x2013;958. 10098.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5592248</ArticleId><ArticleId IdType="pubmed">28689664</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J.S., Ko E.J., Hwang H.S., Lee Y.N., Kwon Y.M., Kim M.C., Kang S.M. Antiviral activity of ginseng extract against respiratory syncytial virus infection. Int J Mol Med. 2014;34(1):183&#x2013;190.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4072342</ArticleId><ArticleId IdType="pubmed">24756136</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J.S., Lee Y.N., Lee Y.T., Hwang H.S., Kim K.H., Ko E.J., Kim M.C., Kang S.M. Ginseng protects against respiratory syncytial virus by modulating multiple immune cells and inhibiting viral replication. Nutrients. 2015;7(2):1021&#x2013;1036.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4344572</ArticleId><ArticleId IdType="pubmed">25658239</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J.S., Cho M.K., Hwang H.S., Ko E.J., Lee Y.N., Kwon Y.M., Kim M.C., Kim K.H., Lee Y.T., Jung Y.J., et al. Ginseng diminishes lung disease in mice immunized with formalin-inactivated respiratory syncytial virus after challenge by modulating host immune responses. J&#xa0;Interferon Cytokine Res. 2014;34(11):902&#x2013;914.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4217040</ArticleId><ArticleId IdType="pubmed">25051168</ArticleId></ArticleIdList></Reference><Reference><Citation>Vohra S., Johnston B.C., Laycock K.L., Midodzi W.K., Dhunnoo I., Harris E., Baydala L. Safety and tolerability of North American ginseng extract in the treatment of pediatric upper respiratory tract infection: a phase II randomized, controlled trial of 2 dosing schedules. Pediatrics. 2008;122(2):e402&#x2013;e410.</Citation><ArticleIdList><ArticleId IdType="pubmed">18676527</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie X, Hu L, Xue H, Xiong Y, Panayi AC, Lin Z, Chen L, Yan C, Zhou W, Mi B, et&#xa0;al. Prognosis and treatment of complications associated with COVID-19: a systematic review and meta-analysis. Acta Materia Medica.1(1):124-137.</Citation></Reference><Reference><Citation>Yang J, Yang Y. Regulatory lessons from China&#x2019;s COVID-19 vaccines development and approval policies. Acta Materia Medica.1(1):96-105.</Citation></Reference><Reference><Citation>Oesch F., Oesch-Bartlomowicz B., Efferth T. Toxicity as prime selection criterion among SARS-active herbal medications. Phytomedicine. 2021;85</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7840405</ArticleId><ArticleId IdType="pubmed">33593628</ArticleId></ArticleIdList></Reference><Reference><Citation>Park H.H., Kim H., Lee H.S., Seo E.U., Kim J.E., Lee J.H., Mun Y.H., Yoo S.Y., An J., Yun M.Y., et al. PEGylated nanoparticle albumin-bound steroidal ginsenoside derivatives ameliorate SARS-CoV-2-mediated hyper-inflammatory responses. Biomaterials. 2021;273</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8046382</ArticleId><ArticleId IdType="pubmed">33910079</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma P., Tyagi A., Bhansali P., Pareek S., Singh V., Ilyas A., Mishra R., Poddar N.K. Saponins: extraction, bio-medicinal properties and way forward to anti-viral representatives. Food Chem Toxicol. 2021;150</Citation><ArticleIdList><ArticleId IdType="pubmed">33617964</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C., Liu J., Deng J., Wang J., Weng W., Chu H., Meng Q. Advances in the chemistry, pharmacological diversity, and metabolism of 20(R)-ginseng saponins. J&#xa0;Ginseng Res. 2020;44(1):14&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7033361</ArticleId><ArticleId IdType="pubmed">32095093</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>